 |
Human donor haematopoietic stem and progenitor cells that have been treated ex vivo with the protein transduction domain of the HIV-1 transactivation protein fused to MYC transcription factor |
|---|---|
| Trade Name | |
| Orphan Indication | Treatment in haematopoietic stem cell transplantation |
| EU Market Approval | EU |
| EU Designation Date | 2017-01-12 00:00:00 |
| Sponsor | Coté Orphan Consulting UK Limited |
